Three weeks of microplastic exposure produces Alzheimer’s-like changes in genetically modified mice, study finds

Researchers at the University of Rhode Island reported that just three weeks of exposure to polystyrene microplastics produced behavioral and cognitive changes in genetically modified mice that the team says resemble signs of Alzheimer’s disease.

In the study, mice engineered to carry the human APOE4 mutation—a well-established genetic risk factor for Alzheimer’s—were given polystyrene microplastics, the type of particles derived from Styrofoam and similar foams, in their diet and water for a 21-day period. Male mice exposed to the particles displayed altered exploratory behavior, wandering the test arena rather than remaining near a corner for safety, while female mice showed impairments on object-recognition tasks and maze performance, measures commonly used to assess memory in rodents.

Microplastics are defined as particles smaller than a grain of sand that can leach from food containers, water, textiles and some children’s products. The researchers reported that such particles can enter the bloodstream and accumulate in organs including the brain and heart, where they may trigger inflammation or other changes linked to lasting damage.

The study’s principal finding is a sex-specific pattern of behavioral change: researchers interpreted male mice’s decreased preference for safe corners as a form of apathy or reduced anxiety-like behavior, and they characterized the females’ poorer performance on recognition and maze tasks as memory impairment. The authors contend these patterns parallel clinical observations in humans with Alzheimer’s disease, in which men sometimes present with apathy and women more frequently show early memory deficits.

The experiment was conducted in mice carrying APOE4, which predisposes animals—and in humans, increases the risk—for Alzheimer’s-related pathology. The researchers noted that using a genetic model of susceptibility may have amplified the observable effects of short-term exposure, and they cautioned that animal results do not directly equate to human outcomes.

Experts not involved in the study have previously pointed to several reasons for caution when extrapolating from rodent microplastic experiments to human health risks. Differences include the dose and size distribution of microplastics used in laboratory exposures, the route of exposure, and how particles are processed by human tissues. The University of Rhode Island team acknowledged these limitations and called for further studies to determine relevant exposure levels for people, the mechanisms by which particles might affect neural tissue, and whether similar effects occur in other animal models.

The findings add to a growing body of laboratory research examining biological effects of microplastics, a class of pollutants that has attracted increasing attention from scientists and regulators. Microplastics have been detected in food, drinking water, household dust and the environment, and researchers are investigating how widespread exposure might affect human organs over time.

The authors urged additional research to establish dose–response relationships, to test other particle types that people encounter, and to explore whether genetic risk factors such as APOE4 interact with microplastic exposure to alter disease risk. They also recommended investigation into how microplastics distribute across tissues and whether they provoke inflammatory or neurodegenerative processes seen in Alzheimer’s disease.

Until more data are available, the study’s authors and outside scientists emphasized the need for measured interpretation. The results highlight a potential pathway by which environmental contaminants could influence neurological health in genetically susceptible populations, but they stop short of demonstrating that short-term microplastic exposure causes Alzheimer’s disease in humans.